Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OXTR | P30559 | 16/20 | 0.75 |
| ▸ | AVPR2 | P30518 | 13/20 | 0.75 |
| ▸ | AVPR1A | P37288 | 11/20 | 0.75 |
| ▸ | AVPR1B | P47901 | 12/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cargutocin SCHEMBL1643445 | 1.00 | OXTR (0.75) | OXTRAVPR2AVPR1AAVPR1B | |
| Cargutocin SCHEMBL1649343 | 1.00 | OXTR (0.75) | OXTRAVPR2AVPR1AAVPR1B | |
| Cargutocin SCHEMBL14060161 | 1.00 | OXTR (0.75) | OXTRAVPR2AVPR1AAVPR1B | |
| SCHEMBL19003799 | 0.92 | OXTR (0.69) | OXTRAVPR2AVPR1AAVPR1B | |
| SCHEMBL20459016 | 0.92 | OXTR (0.69) | OXTRAVPR2AVPR1AAVPR1B | |
| SCHEMBL17150586 | 0.92 | OXTR (0.69) | OXTRAVPR2AVPR1AAVPR1B | |
| SCHEMBL15511850 | 0.88 | OXTR (0.88) | OXTRAVPR2AVPR1AAVPR1B | |
| SCHEMBL15512193 | 0.88 | OXTR (0.80) | OXTRAVPR2AVPR1AAVPR1B | |
| SCHEMBL18656317 | 0.86 | OXTR (0.74) | OXTRAVPR2AVPR1AAVPR1B | |
| SCHEMBL17150785 | 0.86 | OXTR (0.62) | OXTRAVPR2AVPR1AAVPR1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114239463-B | Battery cluster state of charge correction method based on big data | 杭州科工电子科技有限公司 | 2022-11-01 | — | — | CN | disclosed |
| CN-114239463-A | Battery cluster state of charge correction method based on big data | 杭州科工电子科技有限公司 | 2022-03-25 | — | — | CN | disclosed |